2003 list of steroid users

Laws and Penalties:  Concerns over growing illegal AAS abuse by teenagers, and many of the just discussed long-term effects, led Congress in 1991 to place the whole AAS class of drugs into Schedule III of the Controlled Substances Act (CSA).  Under this legislation, AAS are defined as any drug or hormonal substance, chemically and pharmacologically related to T (other than estrogens, progestins, and corticosteroids) that promotes muscle growth.  The possession or sale of AAS without a valid prescription is illegal.  Since 1991, simple possession of illegally obtained AAS carry a maximum penalty of one year in prison and a minimum $1,000 fine if this is an individual’s first drug offense.  The maximum penalty for trafficking (selling or possessing enough to be suspected of selling) is five years in prison and a fine of $250,000 if this is the individual’s first felony drug offense.  If this is the second felony drug offense, the maximum period of imprisonment and the maximum fine both double.  While the above listed penalties are for federal offenses, individual states have also implemented fines and penalties for illegal use of AAS.  State executive offices have also recognized the seriousness of AAS abuse and other drugs of abuse in schools. For example, the State of Virginia enacted a law that will allow student drug testing as a legitimate school drug prevention program (48, 49).

Nanomedicine  is simply the application of nanotechnologies in a healthcare setting and the majority of benefits that have already been seen involve the use of  nanoparticles  to improve the behaviour of drug substances. Today, nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain,  asthma  and emphysema. The nanomedicines that are currently available are overcoming some of the difficulties experienced by normal medical approaches in delivering the benefit from the drug molecules used. In some cases the drugs have very little solubility in water and the human body struggles to absorb enough to treat the condition.  In other cases, the drug molecule is absorbed well but the body removes the drug before it has had long enough to provide a benefit.  Drugs may lead to side-effects due to poor delivery at the actual site of disease.  For example, drugs that are targeting cancers must avoid healthy tissues and organs or damage can be caused.  Nanomedicines therefore can play an important role in ensuring enough of the drug enters the body, that drug that does enter stays in the body for long periods and is targeted specifically to the areas that need treatment.

The most common side effect of topical corticosteroid use is skin atrophy. All topical steroids can induce atrophy, but higher potency steroids, occlusion, thinner skin, and older patient age increase the risk. The face, the backs of the hands, and intertriginous areas are particularly susceptible. Resolution often occurs after discontinuing use of these agents, but it may take months. Concurrent use of topical tretinoin (Retin-A) % may reduce the incidence of atrophy from chronic steroid applications. 30 Other side effects from topical steroids include permanent dermal atrophy, telangiectasia, and striae.

It could be argued that aromatization is a non-issue, as an . could always be employed to counter estrogen conversion. This is true, but I believe there is a simpler way to go about it. In my opinion, the ideal pre-contest MPD cycle should consist of a low dose of testosterone propionate (150-200 mg/week), as at least some estrogen is needed to maintain a healthy looking skin tone. This should be combined with 2-3 other anabolics; preferably 1-2 oral anabolics and 1-2 injectables anabolics. Some good examples of orals include: Anavar, Epistane, and Turinabol. As for injectables, most people usually find the following drugs to be compatible: Primo, Boldenone, and Dihydroboldenone (1-testosterone).

Given YK11’s ability to significantly increase Follistatin production, along with its relatively weak activity at the androgen receptor, it’s likely that its myotrophic effects are mediated primarily through myostatin inhibition. If so, this would make YK11 a solid addition to just about any PED program, aside from those which already incorporate myostatin inhibitors. In my opinion, YK11 is one of the most interesting compounds to hit the market in recent years, but at this point most bodybuilders appear to be unaware, or at least unconcerned with its existence. I expect that to change in the days ahead, as we continue to learn more about it.

2003 list of steroid users

2003 list of steroid users

It could be argued that aromatization is a non-issue, as an . could always be employed to counter estrogen conversion. This is true, but I believe there is a simpler way to go about it. In my opinion, the ideal pre-contest MPD cycle should consist of a low dose of testosterone propionate (150-200 mg/week), as at least some estrogen is needed to maintain a healthy looking skin tone. This should be combined with 2-3 other anabolics; preferably 1-2 oral anabolics and 1-2 injectables anabolics. Some good examples of orals include: Anavar, Epistane, and Turinabol. As for injectables, most people usually find the following drugs to be compatible: Primo, Boldenone, and Dihydroboldenone (1-testosterone).

Media:

2003 list of steroid users2003 list of steroid users2003 list of steroid users2003 list of steroid users2003 list of steroid users

http://buy-steroids.org